Effects of apo B and apo E gene polymorphisms on lipid and apolipoprotein concentrations after a test meal

Clinica Chimica Acta

Volumn 253, Issue 1-2, 1996, Pages 127-143

  Regis Bailly, Anne ^a   Visvikis, Sophie ^a   Steinmetz, Josiane ^a   Fournier, Blandine ^a   Gueguen, René ^a   Siest, Gérard ^a  

^a Centre du Medicament URA CNRS 597   (France)

Author keywords

Apo B; Apo E; Genetic polymorphisms; Lipid metabolism; Postprandial lipaemia

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CONTROLLED STUDY; FOOD INTAKE; GENETIC POLYMORPHISM; HUMAN; HUMAN EXPERIMENT; LIPID ANALYSIS; LIPID METABOLISM; NORMAL HUMAN; PRIORITY JOURNAL; VARIANCE;

NICOTIANA TABACUM;

EID: 0030607124     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/0009-8981(96)06364-4     Document Type: Article

References (51)

1. [1] Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framigham Study. JAMA 1986;256:2835-2838.
2. [2] Bush TL, Fried LP, Barrett-Connor E. Cholesterol, lipoproteins and coronary heart disease in women. Clin Chem 1988;34:B60-B70.
3. [3] Kannel WB. Cholesterol and risk of coronary heart disease and mortality in men. Clin Chem 1988;34:B53-B59.
4. [4] Solymoss BC, Marcil M, Wesdowska E, Gilfix BM, Lesperance J, Campeau L. Relation of coronary artery disease in women < 60 years of age to the combined elevation of serum lipoprotein(a) and total cholesterol to high density cholesterol ratio. Am J Cardiol 1993;72:1215-1219.
5. [5] Brown SA, Chambless LE, Sharrett AR, Gotto AM, Patsch JR. Post-prandial lipemia: Reliability in an Epidemiological Field Study. Am J Epidemiol 1992;136:538-545.
6. [6] Zilversmit DB. Atherogenesis a post-prandial phenomenon. Circulation 1979;60:473-485.
7. [7] Weintraub MS, Eisenberg S, Breslow JL. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprpotein. J Clin Invest 1987b;80:1571-1577.
8. [8] Miesenböck G, Patsch JR. Post-prandial hyperlipemia the search for the atherogenic lipoprotein. Curr Opin Lipidol 1992;3:196-201.
9. [9] Savolainen MJ, Rantala M, Kervinen K et al. Magnitude of dietary effects on plasma cholesterol concentration: role of sex and apolipoprotein E phenotype. Atherosclerosis 1991;86:145-152.
10. [10] Superko HR. Effects of acute and chronic alcohol consumption on postprandial lipaemia in healthy normotriglyceridemic men. Am J Cardiol 1992;69:701-704.
11. [11] Brown AJ, Roberts DCK. The effect of fasting triacylglyceride concentration and apolipoprotein E polymorphism on post-prandial lipaemia. Arterioscler Thromb 1991;11:1737-1744.
12. [12] Boerwinkle E, Brown S, Sharrett AR, Heiss G, Patsch W, Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentrations. Am J Hum Genet 1994;54:341-360.
13. [13] Boerwinkle E, Visvikis S, Welsh D, Steinmetz J, Hanash SM, Sing CF. The use of measured genotype information in the analysis of quantitative phenotypes in man II The role of the apolipoprotein E polymorphism in determining levels, variability and covariability of cholesterol, betalipoprotein, and triglycerides in a sample of unrelated individuals. Am J Med Genet 1987;27:567-582.
14. [14] Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and Atherosclerosis. Arteriosclerosis 1988;8:1-21.
15. [15] Siest G, Visvikis S, Zaiou M et al. The role of genetics in defining reference values and health status. Meth Inform Med 1993;32:255-259.
16. [16] Boerwinkle E, Utermann G. Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism. Am J Hum Genet 1988;42:104-112.
17. [17] Aalto-Setälä K, Gylling H, Helve E et al. Genetic polymorphism of the apolipoprotein B gene locus influences serum LDL-cholesterol level in familial hypercholesterolemia. Hum Genet 1989;82:305-307.
18. [18] Evans AE, Zhang W, Moreel JFR et al. Polymorphisms of the apolipoprotein B and E genes and their relationship to plasma variables in healthy Chinese men. Hum Genet 1993;92:191-197.
19. [19] Visvikis S, Cambou JP, Arveiler D et al. Apolipoprotein B signal peptide polymorphism in patients with myocardial infarction and controls The ECTIM study'. Hum Genet 1993;90:561-565.
20. [20] Xu CF, Tikkanen MJ, Huttunen Jk et al. Apolipoprotein B signal peptide insertion/ deletion polymorphism is associated with Ag epitopes and involved in the determination of serum triglyceride levels. J Lipid Res 1990;31:1255-1261.
21. [21] Commission 'Lipides, lipoprotéines de la Société Française de Biologie Clinique'. Méthode sélectionnée pour le dosage du cholestérol des lipoprotéines non précipitables par le phosphotungstate de sodium en présence de chlorure de magnésium. Inf Scient Biol 1982;2:69.
22. [22] Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
23. [23] Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
24. [24] Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990;31:545-548.
25. [25] Visvikis S, Chan L, Siest G, Drouin P, Boerwinkle E. An insertion/deletion polymorphism in the signal peptide of the human apolipoprotein B gene. Hum Genet 1990;84:373-375.
26. [26] Boerwinkle E, Brown SA, Rohrbach K, Gotto Jr AM, Patsch W. Role of apolipoprotein E and B gene variation in determining response of lipid, lipoprotein. Am J Hum Genet 1991;49:1145-1154.
27. [27] Boerwinkle E, Chen SH, Visvikis S, Hanis CL, Siest G, Chan L. Signal peptide-length variation in human apo B gene Molecular characteristics and association with plasma glucose levels. Diabetes 1991;40:1539-1544.
28. [28] Régis A, Visvikis S, Feldman L et al. Study of the apo B signal peptide polymorphism in coronary angiographied patients In: Biologie Prospective, Comptes rendus du Seme colloque de Pont-à-Mousson, MM Galteau, G Siest, and J Henny, editors, John Libbey Eurotext, Paris 1993;489-494.
29. [29] Cohn JS, Johnson EJ, Millar JS et al. Contribution of apo B-48 and apo B-100 triglyceride-rich lipoproteins (TRL) to postprandial increases in the plasma concentration of TRL triglycerides and retinyl esters. J Lipid Res 1993;34:2033-2040.
30. [30] Cohn JS, McNamara JR, Cohn SD, Ordovas JM, Schaefer EJ. Plasma apolipoprotein changes in the triglyceride rich lipoprotein fraction of human subjects fed a fat rich meal. J Lipid Res 1988;29:925-936.
31. [31] Karpe F, Olivecrona T, Walldius G, Hamsten A, Lipoprotein lipase in plasma after an oral load: relation to free fatty acids. J Lipid Res 1992;33:975-984.
32. [32] Patsch JR, Prasad Q, Gotto AM, Patsch W. High Density Lipoprotein 2: relationship of plasma levels of this lipoprotein specie to its composition, to the magnitude of postprandial lipaemia, and to the activities of lipoprotein lipase and hepatic lipase. J Clin Invest 1987;80:341-347.
33. [33] Cohn JS, McNamara JR, Cohn SD, Ordovas JM, Schaefer EJ. Postprandial plasma lipoprotein changes in human subjects of different ages. J Lipid Res 1988;29:469-479.
34. [34] Rifai N, Merrill JR, Holly RG. Postprandial effect of a high fat meal on plasma lipid, lipoprotein cholesterol and apolipoprotein measurements. Ann Clin Biochem 1990;27:489-493.
35. [35] Barbagallo CM, Averna MR, Amato S et al. Lipid and apoprotein behaviour after oral fat load in hypertriglyceridaemia. Diabetes Metab 1991;17:512-519.
36. [36] O'Meara NM, Lewis GF, Cabana PH, Getz GS, Polonsky KS. Role of basal Triglyceride and High Density Lipoprotein in determination of post-prandial lipid and lipoprotein responses. J Clin Endocrinol Metab 1992;75:465-471.
37. [37] Clifton PM, Nestel PJ. Influence of gender, Body Mass Index and age on response of plasma lipids to dietary fat plus cholesterol. Arterioscler Thromb 1992;12:995-962.
38. [38] Tall A, Sammett D, Granot E. Mechanisms of enhanced cholesteryl ester from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipaemia. J Clin Invest 1986;77:1163-1172.
39. [39] Annuzzi G, Holmquist L, Carlson LA. Concentrations of apolipoproteins B, C-I, C-II, C-III, E and lipids in serum and serum lipoproteins of normal subjects during alimentary lipaemia. Scand J Clin Invest 1989;49:73-81.
40. [40] Dashti N, Wolfbauer G. Secretion of lipids, apolipoproteins, and lipoproteins by human hepatoma cell line, HepG2: effects of oleic acid and insulin. J Lipid Res 1987;28:423-436.
41. [41] Chait A, Bierman EL, Albers JJ. Low density lipoprotein receptor activity in cultured human fibroblast: mechanisms of insulin-induced stimulation. J Clin Invest 1979;64:1309-1319.
42. [42] Mazzone T, Foster D, Chait A. In vivo stimulation of low-density lipoprotein degradation by insulin. Diabetes 1984;33:333-338.
43. [43] Seishima M, Noma A, Torizawa H, Muto Y. Changes of serum apolipoprotein levels after oral administration of fat in human subjects. Atherosclerosis 1988;73:39-43.
44. [44] Demnant T, Bedford D, Packard J, Shepherd J. Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in Normolipemic Subjects. J Clin Invest 1991;88:1490-1501.
45. [45] Gregg RE, Zech LA, Schaefer EJ, Stark D, Wilson D, Brewer,Jr HB. Abnormal in vivo metabolism of apolipoprotein E4 in humans. J Clin Invest 1986;78:815-821.
46. [46] Tozuka M, Hidaka H, Miyachi M, Furihata K, Katsuyama T, Kanai M. Identification and characterisation of apolipoprotein (AII-E2-AII) complex in human plasma lipoprotein. Biochim Biophys Acta 1992;1165:61-67.
47. [47] Visvikis S, Régis A, Aguillon D, Siest G. Genetics of apolipoprotein B. In: Galteau MM, Siest G, Henny J, eds. Biologie Prospective, Comptes rendus du 8eme colloque de Pont-à-Mousson, John Libbey Eurotext, Paris, 1993;89-494.
48. [48] Gaffney D, Freeman DJ, Shepherd J, Packard CJ. The ins/del polymorphism in the signal sequence of apolipoprotein B has no effect on lipid parameters. Clin Chim Acta 1993;18:131-138.
49. [49] Gajra B, Candlish JK, Saha N, Heng CK, Soemantri AG, Tay JSH. Influence of polymorphisms for apolipoprotein B (Ins/Del, Xbal, EcoRI) and apolipoprotein E on serum lipids and apolipoproteins in a Javanese population. Genet Epidemiol 1994;1:19-27.
50. [50] Muls E, Kempen K, Vansant G, Cobbaert C, Saris W. The effects of weight loss and apolipoprotein E polymorphism on serum lipids, apolipoproteins A-I and B, and lipoprotein(a). Int J Obesity 1993;17:711-716.
51. [51] Ditschuneit HH, Flechtner-Mors M, Knispel D, Ditschuneit H. The effects of an oral fat load on serum lipoproteins in obesity. Nutr Metab Cardiovasc Dis 1994;4:20-27.